课题基金 / 基金详情

Co-localizing Quantitative Trait Loci for Bone Mineral Density and HDL in Mice

Co-localizing Quantitative Trait Loci for Bone Mineral Density and HDL in Mice
小鼠骨矿物质密度和 HDL 的定量性状基因座的共定位
批准号:
8277798
负责人:
Cheryl Lynne Ackert-Bicknell
金额:
$31.05万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-20 至 2015-05-31

项目摘要

项目成果

Cheryl Lynne Ackert-Bicknell的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Half of all Americans either have or are at serious risk for developing osteoporosis. Bone mineral density (BMD) can be readily measured in a clinical setting, and low BMD is associated with increased risk of osteoporotic fracture. Cardiovascular disease (CVD) is a major cause of death in industrialized societies, and it is well established that raising HDL cholesterol reduces the risk of cardiovascular disease. Studies have shown that low BMD can be used as an independent predictor of CVD, and patients with CVD are more likely to have low BMD. Smoking, lack of exercise and eating a high fat "Western" diet increases the risk of developing both CVD and osteoporosis. Together these suggest that there may be shared causes for these two diseases. Both BMD and serum HDL levels have been shown to be genetically regulated. Preliminary studies in humans have suggested the existence of shared genetic causes for both of these phenotypes, but, as environmental and lifestyle factors influence both BMD and serum HDL levels, identifying the genetic link between CVD and osteoporosis has been difficult. The mouse is an excellent model for mapping genes that underlie complex traits, and, unlike in human studies, environment can be controlled and modulated as needed in studies using the mouse. Two quantitative trait loci (QTL) for BMD have been identified on mouse Chromosome 1 and 8 that are coincident for QTL for serum HDL. Furthermore, both of these BMD QTL interact with dietary cholesterol intake. The Chr 1 QTL has been narrowed down to one gene, and the Chr 8 QTL has been narrowed down to 4 candidate genes. In this application, a knockout mouse for the candidate gene on Chr 1 will be developed to confirm that: 1) this gene underlies the BMD QTL on Chr 1; 2) this QTL interacts with dietary cholesterol intake to affect BMD; and 3) this same gene regulates serum HDL levels. In the second Aim, the gene underlying the BMD QTL on Chr 8 will be identified, and the hypothesis that a single gene at this locus regulates both the BMD and HDL QTL will be confirmed. PUBLIC HEALTH RELEVANCE: Low bone mineral density (BMD) is associated with increased risk of osteoporotic fracture, and low levels of HDL cholesterol are associated with increased risk for heart disease. This research will help us better comprehend and identify the genes that simultaneously regulate BMD and HDL cholesterol levels. Understanding the shared genetic causes of heart disease and osteoporosis will lead to new and better treatments and improve our ability to screen for and prevent these common and debilitating diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Diagnosis and Tracking of Spinal Staphylococcus aureus Orthopaedic Implant Infections
  • 批准号:
    10554426
  • 项目类别:
  • 资助金额:
    $23.18万
  • 财政年份:
    2022
  • 负责人:
    Cheryl Lynne Ackert-Bicknell
  • 依托单位:
Diagnosis and Tracking of Spinal Staphylococcus aureus Orthopaedic Implant Infections
  • 批准号:
    10464246
  • 项目类别:
  • 资助金额:
    $20.71万
  • 财政年份:
    2022
  • 负责人:
    Cheryl Lynne Ackert-Bicknell
  • 依托单位:
Identification of Novel Genes Impacting Osteoblast Activity
  • 批准号:
    10649471
  • 项目类别:
  • 资助金额:
    $68.35万
  • 财政年份:
    2021
  • 负责人:
    Cheryl Lynne Ackert-Bicknell
  • 依托单位:
Identification of Novel Genes Impacting Osteoblast Activity
  • 批准号:
    10312427
  • 项目类别:
  • 资助金额:
    $71.1万
  • 财政年份:
    2021
  • 负责人:
    Cheryl Lynne Ackert-Bicknell
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: